RECURRENT NASOPHARYNGEAL CARCINOMA
Clinical trials for RECURRENT NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double immunotherapy may keep nasopharyngeal cancer at bay
Disease control Recruiting nowThis phase II trial tests whether adding the immunotherapy drug relatlimab to standard nivolumab maintenance therapy can extend the time before cancer grows or spreads in patients with recurrent or metastatic nasopharyngeal cancer linked to Epstein-Barr virus. Participants first …
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
Immunotherapy boost may improve outcomes in returning throat cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug (PD-1 antibody) to standard chemoradiotherapy helps people with recurrent nasopharyngeal carcinoma live longer. About 212 participants whose cancer has returned after prior treatment and cannot be surgically removed wi…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New surgery technique could improve survival in recurrent throat cancer
Disease control Recruiting nowThis study compares two surgical techniques for treating nasopharyngeal cancer that has come back after radiation. 500 participants will be randomly assigned to receive either low-temperature plasma ablation or high-frequency electrocautery. The goal is to see which method leads …
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Proton beam takes aim at returning throat cancer
Disease control Recruiting nowThis study is testing a precise type of radiation called proton therapy for people whose nasopharyngeal cancer has come back. The goal is to see if it can control the cancer while causing fewer severe side effects than standard treatments. About 52 adults with recurrent, non-spre…
Matched conditions: RECURRENT NASOPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC